Lombard Medical Inc (EVAR) reported quarterly earnings results on Monday, Aug-22-2016. The company reported $-0.42 earnings per share for the quarter, missing the analyst consensus estimate by $-0.03. Analysts had a consensus of $-0.39. The company posted revenue of $3.80 million in the period, compared to analysts expectations of $3.78 million. The company’s revenue was down -16.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.51 EPS.
Lombard Medical Inc closed down -0.03 points or -2.68% at $1.09 with 32,743 shares getting traded on Friday. Post opening the session at $1.12, the shares hit an intraday low of $1.05 and an intraday high of $1.15 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
Lombard Medical Inc. is a medical technology company. The Company specializes in developing manufacturing and marketing endovascular stent-grafts for repair of aortic aneurysms. Its lead product Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of up to 90 degrees. It supplies Aorfix pre-loaded into a delivery system Aorflex which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is placed within the abdominal aorta it provides a conduit for blood flow thereby relieving pressure within the weakened or aneurysmal section of the vessel wall which reduces the potential for the AAA to rupture. Its principal brands are Aorfix and Aorflex. Outside of the United States it markets Aorfix through its direct sales forces in Germany and the United Kingdom and through distribution agreements with partners in other European Union countries Latin America and Asia.